Gravani, A.; Gaitanis, G.; Spyridonos, P.; Alexis, I.; Tigas, S.; Bassukas, I.D.
Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis. J. Clin. Med. 2022, 11, 3193.
https://doi.org/10.3390/jcm11113193
AMA Style
Gravani A, Gaitanis G, Spyridonos P, Alexis I, Tigas S, Bassukas ID.
Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis. Journal of Clinical Medicine. 2022; 11(11):3193.
https://doi.org/10.3390/jcm11113193
Chicago/Turabian Style
Gravani, Agoritsa, Georgios Gaitanis, Panagiota Spyridonos, Ioannis Alexis, Stelios Tigas, and Ioannis D. Bassukas.
2022. "Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis" Journal of Clinical Medicine 11, no. 11: 3193.
https://doi.org/10.3390/jcm11113193
APA Style
Gravani, A., Gaitanis, G., Spyridonos, P., Alexis, I., Tigas, S., & Bassukas, I. D.
(2022). Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis. Journal of Clinical Medicine, 11(11), 3193.
https://doi.org/10.3390/jcm11113193
